Search

Dr. Chi, a physician-scientist and member of the Human Oncology and Pathogenesis Program, studies genetic and epigenetic changes that cause cancer.

… Friday, November 2, 2012 Summary Dr. Chi, a physician-scientist and member of the Human Oncology and Pathogenesis Program, studies genetic and epigenetic changes that cause cancer. Ping Chi , a member of Memorial Sloan Kettering’s Human Oncology and Pathogenesis Program (HOPP) , is a laboratory investigator

Memorial Sloan Kettering social worker Melissa Stewart has been awarded the Assocation of Oncology Social Work (AOSW)’s Dennis Roth Neuro-Oncology Social Worker of the Year for 2010. She will be honored at the AOSW conference in Phoenix, Arizona on May 2, 2010.

… Thursday, March 25, 2010 Memorial Sloan Kettering social worker Melissa Stewart has been awarded the Assocation of Oncology Social Work (AOSW)’s Dennis Roth Neuro-Oncology Social Worker of the Year for 2010. She will be honored at the AOSW conference in Phoenix, Arizona on May 2, 2010.

The combination of the immunotherapy drug ipilimumab and the investigational antibody drug nivolumab led to long-lasting tumor shrinkage in more than half of patients with metastatic melanoma, according to results from a Phase I trial simultaneously published in The New England Journal of Medicine and presented at the 49th Annual Meeting of the American Society of Clinical Oncology.

… Sunday, June 2, 2013 The combination of the immunotherapy drug ipilimumab and the investigational antibody drug nivolumab led to long-lasting tumor shrinkage in more than half of patients with metastatic melanoma , according to results from a Phase I trial simultaneously published today in The New England

New MSK research finds a way to package protein-degrading drugs called PROTACs into nanoparticles that target blood vessels within solid tumors; identifies genomic markers that predict whether precancerous blood conditions will turn into multiple myeloma; develops a data-driven approach that could catch lymphedema earlier; and shows that nurse-led palliative care delivered by phone could serve as a scalable model.

… Tuesday, December 16, 2025   New research from Memorial Sloan Kettering Cancer Center (MSK) finds a way to package protein-degrading drugs called PROTACs into nanoparticles that target blood vessels within solid tumors; identifies genomic markers that predict whether precancerous blood conditions will

Thanks to a second opinion and minimally invasive surgery at MSK to remove tongue cancer, Karren Tyler is back home in Charlottesville, Virginia, cancer free and focused on giving back to other cancer patients.

… Monday, November 24, 2025 When Karren Tyler noticed a spot on the back of her tongue last year, she had it checked out by a doctor near her home in Charlottesville, Virginia, who told her it was probably nothing to worry about. But a week after having the spot removed and biopsied, Karren learned she

After developing a noninvasive nanosensor to detect the progression of fatty liver disease in mice, researchers at the Sloan Kettering Institute have determined that there is a long-term effect on liver macrophages from eating a high-fat and high-sugar diet, even after switching back to a normal diet.

… Friday, October 12, 2018 Bottom Line: After developing a noninvasive nanosensor to detect the progression of fatty liver disease in mice, researchers at the Sloan Kettering Institute have determined that there is a long-term effect on liver macrophages from eating a high-fat and high-sugar diet, even

Learn about dense breast tissue and what it means for your cancer risk and screening needs.

… Tuesday, May 27, 2025 Having dense breasts is a  risk factor for breast cancer . But how do you know if you have dense breasts, and how should it affect the way you approach screening for the disease? Radiologist Elise Desperito, MD , Director of Breast Imaging at the  MSK Ralph Lauren Center , shares

Learn how a heralded clinical trial for rectal cancer led to Dr. Andrea Cercek of MSK meeting the 4-day-old newborn of her patient, who feared she could not get pregnant.

… Tuesday, November 7, 2023 “Would you like to hold my baby?” Kelly Spill’s question to  Andrea Cercek, MD , is a familiar one from any proud par­ent. But as they sat together surrounded by Kelly’s family on her porch in southern New Jersey, that simple question took on a much more poignant meaning. As

A newly published study demonstrates that imaging with Positron Emission Tomography (PET) using a radiolabeled antibody accurately identifies whether a patient has clear cell renal carcinoma - the most common and aggressive type of renal tumor - and arms the urologist with crucial information that will help determine whether surgery is needed.

… Tuesday, March 6, 2007 The ability to identify an individual’s specific tumor type prior to surgery could have important implications for the management of patients diagnosed with kidney cancer . A newly published study demonstrates that imaging with Positron Emission Tomography (PET) using a radiolabeled

David A. Scheinberg has been elected a member of the prestigious Association of American Physicians (AAP).

… Friday, May 1, 2009 Summary David A. Scheinberg has been elected a member of the prestigious Association of American Physicians (AAP). David A. Scheinberg has been elected a member of the prestigious Association of American Physicians (AAP). Dr. Scheinberg is a physician-scientist involved in both basic